News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,976 Results
Type
Article (43157)
Company Profile (332)
Press Release (670487)
Section
Business (212072)
Career Advice (2187)
Deals (36873)
Drug Delivery (103)
Drug Development (83275)
Employer Resources (173)
FDA (16559)
Job Trends (15435)
News (358361)
Policy (34185)
Tag
Academia (2607)
Alliances (51428)
Alzheimer's disease (1291)
Approvals (16520)
Artificial intelligence (159)
Bankruptcy (368)
Best Places to Work (11759)
Biotechnology (214)
Breast cancer (193)
Cancer (1420)
Cardiovascular disease (116)
Career advice (1833)
Cell therapy (292)
Clinical research (66560)
Collaboration (506)
Compensation (274)
COVID-19 (2638)
C-suite (114)
Data (1407)
Diabetes (180)
Diagnostics (6290)
Earnings (87544)
Employer resources (151)
Events (113812)
Executive appointments (416)
FDA (17270)
Funding (450)
Gene therapy (212)
GLP-1 (642)
Government (4539)
Healthcare (19059)
Infectious disease (2732)
Inflammatory bowel disease (116)
Interviews (340)
IPO (16733)
Job creations (4082)
Job search strategy (1565)
Layoffs (445)
Legal (8432)
Lung cancer (203)
Lymphoma (101)
Manufacturing (224)
Medical device (13385)
Medtech (13390)
Mergers & acquisitions (20316)
Metabolic disorders (485)
Neuroscience (1631)
NextGen Class of 2024 (6671)
Non-profit (4552)
Northern California (1735)
Obesity (277)
Opinion (211)
Patents (126)
People (59038)
Phase I (20622)
Phase II (29262)
Phase III (21966)
Pipeline (521)
Postmarket research (2691)
Preclinical (8775)
Radiopharmaceuticals (246)
Rare diseases (278)
Real estate (6283)
Regulatory (22721)
Research institute (2385)
Resumes & cover letters (368)
Southern California (1491)
Startups (3740)
United States (15642)
Vaccines (592)
Weight loss (201)
Date
Last 7 days (171)
Last 30 days (1628)
Last 365 days (35244)
2025 (91)
2024 (35996)
2023 (40833)
2022 (52030)
2021 (56533)
2020 (55063)
2019 (47721)
2018 (36036)
2017 (33417)
2016 (33004)
2015 (38942)
2014 (32876)
2013 (27985)
2012 (30102)
2011 (30818)
2010 (28857)
Location
Africa (796)
Arizona (205)
Asia (40731)
Australia (6552)
California (3912)
Canada (1480)
China (332)
Colorado (178)
Connecticut (186)
Europe (86981)
Florida (551)
Georgia (137)
Illinois (403)
Indiana (235)
Maryland (648)
Massachusetts (3058)
Michigan (177)
Minnesota (298)
New Jersey (1144)
New York (1114)
North Carolina (777)
Northern California (1735)
Ohio (150)
Pennsylvania (947)
South America (1180)
Southern California (1491)
Texas (570)
Utah (111)
Washington State (410)
713,976 Results for "fresenius kabi pharmaceuticals holding inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio
December 17, 2024
·
6 min read
Press Releases
Fresenius Kabi Receives 2024 Novaplus Program Excellence Award from Vizient
November 14, 2024
·
3 min read
Press Releases
Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies
December 10, 2024
·
6 min read
FDA
Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
According to Fresenius Kabi, Tyenne is the first biosimilar to Genentech’s Acterma which has both IV and subcutaneous formulations approved by the FDA.
March 8, 2024
·
2 min read
·
Tyler Patchen
BioMidwest
Angels for Change 2024 Drug Shortage Guardian Award Presented to Fresenius Kabi USA
Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization’s 2024 Drug Shortage Guardian Award to Fresenius Kabi USA, a health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition.
June 6, 2024
·
4 min read
Press Releases
Fresenius Kabi launches Tyenne®*, the first and only approved tocilizumab biosimilar in Canada
October 18, 2024
·
5 min read
Press Releases
Fresenius Kabi Submits 510(k) Notification for the Aurora Xi Plasmapheresis System Software Version 2.0 with New Nomogram
November 21, 2024
·
4 min read
BioMidwest
Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections
Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections.
January 29, 2024
·
6 min read
BioMidwest
Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP
Fresenius Kabi announced today it has introduced Cyclophosphamide for Injection, USP, a generic substitute for Cytoxan, for use in treating several forms of cancer.
February 28, 2024
·
4 min read
FDA
Fresenius Kabi and Formycon Receive U.S. FDA Approval for Biosimilar Otulfi™* (ustekinumab-aauz)
September 30, 2024
·
5 min read
1 of 71,398
Next
